{"transactions":[{"id":862591,"issuer":{"id":8097,"kind":"organization","name":"20/20 Biolabs, Inc."},"owners":[{"id":62917,"kind":"person","name":"Cohen Jonathan M","position":1,"cik":"0002111543","reported_name":"Cohen Jonathan M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-03-04T22:48:56.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":352936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 3, 2026, the Reporting Person was granted a stock option for the purchase of 352,936 shares of common stock, which shall vest in equal quarterly installments over the following four (4) years, subject to the Reporting Person's continuous service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 3, 2026, the Reporting Person was granted a stock option for the purchase of 352,936 shares of common stock, which shall vest in equal quarterly installments over the following four (4) years, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":352936,"derivative":{"exercise_price":3.39,"expiration_date":"2036-03-03","underlying":"Common Stock","underlying_shares":352936},"source":{"system":"sec-edgar","filing":"0001213900-26-023758","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026023758/ownership.xml","form_type":"4"}}]}